The Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced that 64 drugs available through Medicare Part B will be less expensive for some enrollees from July 1 through September 30 of this year.
“Everyone should be able to afford their medication, and the Inflation Reduction Act continues to deliver on this goal to improve affordability,” said CMS Administrator Chiquita Brooks-LaSure. “Discouraging drug companies from price increases above the rate of inflation is a key part of this effort, and CMS continues to implement the law to bring savings to people with Medicare.”
The HHS release noted, “The Inflation Reduction Act requires drug companies to pay rebates to Medicare when prices increase faster than the rate of inflation for certain drugs.“
As the Lord Leads, Pray with Us…
- For HHS Secretary Becerra and CMS Administrator Brooks-LaSure to receive God’s insight as they oversee the Medicare Prescription Drug Inflation Rebate Program.
- For wisdom for federal health officials as they assess medical and prescription costs.
- For the president and members of his administration to seek insight from the Lord as they make plans and promote policies.
